NCT01097681View on ClinicalTrials.gov

A Study to Assess the Pharmacokinetics, Pharmacodynamics of ASP1941 in Diabetes Mellitus Patients With Renal Impairment

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

February 16, 2010

Primary Completion Date

June 18, 2010

Study Completion Date

June 18, 2010

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

ASP1941

oral

Trial Locations (2)

Unknown

Kansai

Kantou

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY